Abstract/References

Sarcopenia is prevalent among 11–25% of adult cancer survivors, depending on the cancer type, although the available data on post-treatment survivors in Japan are limited. If cancer patients develop cachexia, they may experience sustained weight loss as a result, ultimately leading to sarcopenia. Conversely, some patients experience post-treatment weight gain, resulting in sarcopenic obesity. Both sarcopenia and obesity elevate the risk of cardiovascular diseases and mortality; therefore, the importance of sarcopenia prevention and management is undeniable. The Guidelines for Exercise for Cancer Survivors recommend continued physical activity. Recent studies have reported the effectiveness of multimodal interventions, combining pharmacological, nutritional, and exercise approaches, necessitating multidisciplinary care for post-treatment sarcopenia. Innovative health interventions using mobile devices have also gained attention. However, studies on sarcopenia in post-treatment cancer survivors, especially those regarding exercise interventions, remain scarce in Japan, primarily due to limited insurance coverage for such post-treatment interventions and workforce challenges. It is clear that some cancer survivors have sarcopenia, which can lead to worse survival and secondary illness. While the benefits of exercise are clear, a comprehensive approach to sarcopenia is a further challenge for the future.

1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia:European consensus on definition and diagnosis:Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 39:412-423, 2010.

2. Anjanappa M, Corden M, Green A, et al. Sarcopenia in cancer:Risking more than muscle loss. Tech Innov Patient Support Radiat Oncol, 16:50-57, 2020.

3. Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia:2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc, 21:300-307.e2, 2020.

4. Williams GR, Rier HN, McDonald A, Shachar SS. Sarcopenia & aging in cancer. J Geriatr Oncol, 10:374-377, 2019.

5. Zhang XM, Dou QL, Zeng Y, Yang Y, Cheng ASK, Zhang WW. Sarcopenia as a predictor of mortality in women with breast cancer:a meta-analysis and systematic review. BMC Cancer, 20:172, 2020.

6. Morlino D, Marra M, Cioffi I, et al. Prevalence of Sarcopenia in Women with Breast Cancer. Nutrients, 14:1839, 2022.

7. Surov A, Wienke A. Prevalence of sarcopenia in patients with solid tumors:A meta-analysis based on 81,814 patients. JPEN J Parenter Enteral Nutr, 46:1761-1768, 2022.

8. Davis MP, Panikkar R. Sarcopenia associated with chemotherapy and targeted agents for cancer therapy. Ann Palliat Med, 8:86-101, 2019.

9. Anjanappa M, Corden M, Green A, et al. Sarcopenia in cancer:Risking more than muscle loss. Tech Innov Patient Support Radiat Oncol, 16:50-57, 2020.

10. Sousa IM, Fayh APT. Is the ECOG-PS similar to the sarcopenia status for predicting mortality in older adults with cancer? A prospective cohort study. Support Care Cancer, 31:370, 2023.

11. van Rijn-Dekker MI, van den Bosch L, van den Hoek JGM, et al. Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy. Radiother Oncol, 147:103-110, 2020.

12. Nipp RD, Fuchs G, El-Jawahri A, et al. Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced Cancer. Oncologist, 23:97-104, 2018.

13. Besson A, Deftereos I, Gough K, Taylor D, Shannon R, Yeung JM. Correction to:The association between sarcopenia and quality of life in patients undergoing colorectal cancer surgery:an exploratory study. Support Care Cancer, 29:3421, 2021.

14. Bye A, Sjøblom B, Wentzel-Larsen T, et al. Muscle mass and association to quality of life in non-small cell lung cancer patients. J Cachexia Sarcopenia Muscle, 8:759-767, 2017.

15. Barreto CS, Borges TC, Valentino NP, et al. Absence of risk of sarcopenia protects cancer patients from fatigue. Eur J Clin Nutr, 76:206-211, 2022.

16. Wang B, Thapa S, Zhou T, et al. Cancer-related fatigue and biochemical parameters among cancer patients with different stages of sarcopenia. Support Care Cancer, 28:581-588, 2020.

17. Ito Y, Miyashiro I, Ito H, et al. Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data. Cancer Sci, 105:1480-1486, 2014.

18. Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr, 36:11-48, 2017.

19. Clemente-Suárez VJ, Redondo-Flórez L, Rubio-Zarapuz A, Martínez-Guardado I, Navarro-Jiménez E, Tornero-Aguilera JF. Nutritional and Exercise Interventions in Cancer-Related Cachexia:An Extensive Narrative Review. Int J Environ Res Public Health, 19:4604, 2022.

20. Cortiula F, Hendriks LEL, van de Worp WRPH, et al. Physical exercise at the crossroad between muscle wasting and the immune system:implications for lung cancer cachexia. J Cachexia Sarcopenia Muscle, 13:55-67, 2022.

21. Kurz E, Hirsch CA, Dalton T, et al. Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer. Cancer Cell, 40:720-737.e5, 2022.

22. Koivula T, Lempiäinen S, Rinne P, et al. The effect of acute exercise on circulating immune cells in newly diagnosed breast cancer patients. Sci Rep, 13:6561, 2023.

23. Park YJ, Lee YM. Association among the Prevalence of Sarcopenia without Obesity, Nonsarcopenic Obesity, Sarcopenic Obesity, and Metabolic Syndrome in Cancer Survivors:Based on Korea National Health and Nutrition Examination Survey. Asia Pac J Oncol Nurs, 8:679-686, 2021.

24. Lee SJ, Kim NC. Association Between Sarcopenia and Metabolic Syndrome in Cancer Survivors. Cancer Nurs, 40:479-487, 2017.

25. Aduse-Poku L, Karanth SD, Wheeler M, et al. Associations of Total Body Fat Mass and Skeletal Muscle Index with All-Cause and Cancer-Specific Mortality in Cancer Survivors. Cancers (Basel), 15:1081, 2023.

26. Kim EY, Kim K, Kim YS, et al. Prevalence of and Factors Associated with Sarcopenia in Korean Cancer Survivors:Based on Data Obtained by the Korea National Health and Nutrition Examination Survey (KNHANES) 2008-2011. Nutr Cancer, 69:394-401, 2017.

27. Lee SJ, Park YJ, Cartmell KB. Sarcopenia in cancer survivors is associated with increased cardiovascular disease risk. Support Care Cancer, 26:2313-2321, 2018.

28. Villaseñor A, Ballard-Barbash R, Baumgartner K, et al. Prevalence and prognostic effect of sarcopenia in breast cancer survivors:the HEAL Study. J Cancer Surviv, 6:398-406, 2012.

29. Benavides-Rodríguez L, García-Hermoso A, Rodrigues-Bezerra D, Izquierdo M, Correa-Bautista JE, Ramírez-Vélez R. Relationship between Handgrip Strength and Muscle Mass in Female Survivors of Breast Cancer:A Mediation Analysis. Nutrients, 9:695, 2017.

30. van Atteveld JE, de Winter DTC, Pluimakers VG, et al. Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LATER):a cross-sectional study. Lancet Healthy Longev, 4:e155-e165, 2023.

31. McCastlain K, Howell CR, Welsh CE, et al. The Association of Mitochondrial Copy Number With Sarcopenia in Adult Survivors of Childhood Cancer. J Natl Cancer Inst, 113:1570-1580, 2021.

32. Takahashi S, Shimizu S, Nagai S, Watanabe H, Nishitani Y, Kurisu Y. Characteristics of sarcopenia after distal gastrectomy in elderly patients. PLoS One, 14:e0222412, 2019.

33. Hijikata N, Ishikawa A, Matsuda S, et al. Effect of Postoperative Oral Intake Status on Sarcopenia Six Months After Esophageal Cancer Surgery [published correction appears in Dysphagia. 2022 Dec 21;:]. Dysphagia, 38:340-350, 2023.

34. Nakayama H, Noguchi M, Fukano R, et al. Sarcopenia and obesity in long-term survivors of childhood leukemia/lymphoma:a report from a single institution. Jpn J Clin Oncol, 51:1100-1106, 2021.

35. Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and Cancer:A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management. Cancers (Basel), 15:485, 2023.

36. Mostoufi-Moab S, Ginsberg JP, Bunin N, et al. Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation. J Pediatr, 160:122-128, 2012.

37. Kohara K. Sarcopenic obesity in aging population:current status and future directions for research. Endocrine, 45:15-25, 2014.

38. Kohara K, Ochi M, Tabara Y, Nagai T, Igase M, Miki T. Arterial stiffness in sarcopenic visceral obesity in the elderly:J-SHIPP study. Int J Cardiol, 158:146-148, 2012.

39. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts:a population-based study. Lancet Oncol, 9:629-635, 2008.

40. Veronese N, Facchini S, Stubbs B, et al. Weight loss is associated with improvements in cognitive function among overweight and obese people:A systematic review and meta-analysis. Neurosci Biobehav Rev, 72:87-94, 2017.

41. Tschann P, Weigl MP, Clemens P, et al. Sarcopenic Obesity Is a Risk Factor for Worse Oncological Long-Term Outcome in Locally Advanced Rectal Cancer Patients:A Retrospective Single-Center Cohort Study. Nutrients, 15:2632, 2023.

42. Malhotra P, Kapoor G, Jain S, Jain S, Sharma A. Obesity and Sarcopenia in Survivors of Childhood Acute Lymphoblastic Leukemia. Indian Pediatr, 58:436-440, 2021.

43. Marriott CJC, Beaumont LF, Farncombe TH, et al. Body composition in long-term survivors of acute lymphoblastic leukemia diagnosed in childhood and adolescence:A focus on sarcopenic obesity. Cancer, 124:1225-1231, 2018.

44. Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB. Anthracycline cardiotoxicity:from bench to bedside. J Clin Oncol, 26:3777-3784, 2008.

45. Ewer SM, Ewer MS. Cardiotoxicity profile of trastuzumab. Drug Saf, 31:459-467, 2008.

46. Choueiri TK, Mayer EL, Je Y, et al. Congestive heart failure risk in patients with breast cancer treated with bevacizumab. J Clin Oncol, 29:632-638, 2011.

47. Okwuosa TM, Anzevino S, Rao R. Cardiovascular disease in cancer survivors. Postgrad Med J, 93:82-90, 2017.

48. Florido R, Daya NR, Ndumele CE, et al. Cardiovascular Disease Risk Among Cancer Survivors:The Atherosclerosis Risk In Communities (ARIC) Study. J Am Coll Cardiol, 80:22-32, 2022.

49. Rugbjerg K, Mellemkjaer L, Boice JD, Køber L, Ewertz M, Olsen JH. Cardiovascular disease in survivors of adolescent and young adult cancer:a Danish cohort study, 1943-2009. J Natl Cancer Inst, 106:dju110, 2014.

50. Fitzgerald MD, Tanaka H, Tran ZV, Seals DR. Age-related declines in maximal aerobic capacity in regularly exercising vs. sedentary women:a meta-analysis. J Appl Physiol (1985), 83:160-165, 1997.

51. Lee K. Sarcopenic obesity and 10-year cardiovascular disease risk scores in cancer survivors and non-cancer participants using a nationwide survey. Eur J Cancer Care (Engl), 32:e13365, 2021

52. Koene RJ, Prizment AE, Blaes A, Konety SH. Shared Risk Factors in Cardiovascular Disease and Cancer. Circulation, 133:1104-1114, 2016

53. Argilés JM, Busquets S, Stemmler B, López-Soriano FJ. Cancer cachexia:understanding the molecular basis. Nat Rev Cancer, 14:754-762, 2014.

54. Arai H, Maeda K, Wakabayashi H, et al. Diagnosis and outcomes of cachexia in Asia:Working Consensus Report from the Asian Working Group for Cachexia. J Cachexia Sarcopenia Muscle, 14:1949-1958, 2023.

55. Antoun S, Morel H, Souquet PJ, et al. Staging of nutrition disorders in non-small-cell lung cancer patients:utility of skeletal muscle mass assessment. J Cachexia Sarcopenia Muscle, 10:782-793, 2019.

56. Dunne RF, Roussel B, Culakova E, et al. Characterizing cancer cachexia in the geriatric oncology population. J Geriatr Oncol, 10:415-419, 2019.

57. Takayama K, Atagi S, Imamura F, et al. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study. Support Care Cancer, 24:3473-3480, 2016.

58. Naito T, Okayama T, Aoyama T, et al. Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer. BMC Cancer, 17:571, 2017.

59. Rock CL, Thomson CA, Sullivan KR, et al. American Cancer Society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin, 72:230-262, 2022.

60. Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise Guidelines for Cancer Survivors:Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc, 51:2375-2390, 2019.

61. Morishita S, Suzuki K, Okayama T, et al. Recent Findings in Physical Exercise for Cancer Survivors. Phys Ther Res, 26:10-16, 2023.

62. Ng AH, Ngo-Huang A, Vidal M, et al. Exercise Barriers and Adherence to Recommendations in Patients With Cancer. JCO Oncol Pract, 17:e972-e981, 2021.

63. Coletta AM, Marquez G, Thomas P, et al. Clinical factors associated with adherence to aerobic and resistance physical activity guidelines among cancer prevention patients and survivors. PLoS One, 14:e0220814, 2019.

64. Upshaw JN, Hubbard RA, Hu J, et al. Physical activity during and after breast cancer therapy and associations of baseline physical activity with changes in cardiac function by echocardiography. Cancer Med, 9:6122-6131, 2020.

65. Kasahara R, Fujita T, Jinbo R, et al. Impact of Sarcopenia on Outcome of Exercise Therapy in Older Non-Hodgkin Lymphoma Patients. Integr Cancer Ther, 22:15347354231210775, 2023.

66. Cao A, Ferrucci LM, Caan BJ, Irwin ML. Effect of Exercise on Sarcopenia among Cancer Survivors:A Systematic Review. Cancers (Basel), 14:786, 2022.

67. Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, et al. Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer:A Randomized Controlled Trial [published correction appears in J Clin Oncol. 2020 Apr 20;38(12):1370] [published correction appears in J Clin Oncol. 2020 Jun 20;38(18):2115]. J Clin Oncol, 36:875-883, 2018.

68. Katakami N, Uchino J, Yokoyama T, et al. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia:Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04). Cancer, 124:606-616, 2018.

69. Hamauchi S, Furuse J, Takano T, et al. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia. Cancer, 125:4294-4302, 2019.

70. Mouri T, Naito T, Morikawa A, et al. Promotion of Behavioral Change and the Impact on Quality of Life in Elderly Patients with Advanced Cancer:A Physical Activity Intervention of the Multimodal Nutrition and Exercise Treatment for Advanced Cancer Program. Asia Pac J Oncol Nurs, 5:383-390, 2018.

71. Naito T, Mitsunaga S, Miura S, et al. Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer. J Cachexia Sarcopenia Muscle, 10:73-83, 2019.

72. Yennurajalingam S, Basen-Engquist K, Reuben JM, et al. Anamorelin combined with physical activity, and nutritional counseling for cancer-related fatigue:a preliminary study. Support Care Cancer, 30:497-509, 2022.

73. Takayama K, Takiguchi T, Komura N, Naito T. Efficacy and safety of anamorelin in patients with cancer cachexia:Post-hoc subgroup analyses of a placebo-controlled study. Cancer Med, 12:2918-2928, 2023.

74. Liu X, Xu X, Cheung DST, et al. The effects of exercise with or without dietary advice on muscle mass, muscle strength, and physical functioning among older cancer survivors:a meta-analysis of randomized controlled trials [published online ahead of print, 2023 Jun 2]. J Cancer Surviv, 1-9, 2023.

75. Grande AJ, Silva V, Riera R, et al. Exercise for cancer cachexia in adults. Cochrane Database Syst Rev, (11):CD010804, 2014.

76. Grande AJ, Silva V, Sawaris Neto L, Teixeira Basmage JP, Peccin MS, Maddocks M. Exercise for cancer cachexia in adults. Cochrane Database Syst Rev, 3:CD010804, 2021.

77. Edvardsen E, Skjønsberg OH, Holme I, Nordsletten L, Borchsenius F, Anderssen SA. High-intensity training following lung cancer surgery:a randomised controlled trial. Thorax, 70:244-250, 2015.

78. Tsuji K, Ochi E, Okubo R, et al. Effect of home-based high-intensity interval training and behavioural modification using information and communication technology on cardiorespiratory fitness and exercise habits among sedentary breast cancer survivors:habit-B study protocol for a randomised controlled trial. BMJ Open, 9:e030911, 2019.

79. Ochi E, Tsuji K, Narisawa T, et al. Cardiorespiratory fitness in breast cancer survivors:a randomised controlled trial of home-based smartphone supported high intensity interval training. BMJ Support Palliat Care, 12:33-37, 2022.

80. Onyeaka HK, Zambrano J, Longley RM, Celano CM, Naslund JA, Amonoo HL. Use of digital health tools for health promotion in cancer survivors. Psychooncology, 30:1302-1310, 2021.

81. Martin-Martin L, et al. A Mobile System to Improve Quality of Life Via Energy Balance in Breast Cancer Survivors (BENECA mHealth):Prospective Test-Retest Quasiexperimental Feasibility Study. JMIR Mhealth Uhealth, 7:e14136, 2019.

82. Lozano-Lozano M, Galiano-Castillo N, Gonzalez-Santos A, et al. Effect of mHealth plus occupational therapy on cognitive function, mood and physical function in people after cancer:Secondary analysis of a randomized controlled trial. Ann Phys Rehabil Med, 66:101681, 2023.

83. Lozano-Lozano M, Martín-Martín L, Galiano-Castillo N, et al. Mobile health and supervised rehabilitation versus mobile health alone in breast cancer survivors:Randomized controlled trial. Ann Phys Rehabil Med, 63:316-324, 2020.

84. Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, et al. Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors:a randomized controlled trial. Breast Cancer Res, 20:124, 2018.

85. Rogers LQ, Courneya KS, Anton PM, et al. Effects of the BEAT Cancer physical activity behavior change intervention on physical activity, aerobic fitness, and quality of life in breast cancer survivors:a multicenter randomized controlled trial. Breast Cancer Res Treat, 149:109-119, 2015.

86. Toohey K, Pumpa K, McKune A, et al. The impact of high-intensity interval training exercise on breast cancer survivors:a pilot study to explore fitness, cardiac regulation and biomarkers of the stress systems. BMC Cancer, 20:787, 2020

87. Pinto BM, Papandonatos GD, Goldstein MG, Marcus BH, Farrell N. Home-based physical activity intervention for colorectal cancer survivors. Psychooncology, 22:54-64, 2013.

88. Adams SC, DeLorey DS, Davenport MH, et al. Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors:A phase 2 randomized controlled trial. Cancer, 123:4057-4065, 2017.

89. Sase K, Kida K, Furukawa Y. Cardio-Oncology rehabilitation- challenges and opportunities to improve cardiovascular outcomes in cancer patients and survivors. J Cardiol, 76:559-567, 2020.

90. Kawaguchi Y, Hanaoka J, Ohshio Y, et al. Sarcopenia increases the risk of post-operative recurrence in patients with non-small cell lung cancer. PLoS One, 16:e0257594, 2021.

91. Nelke C, Dziewas R, Minnerup J, Meuth SG, Ruck T. Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine, 49:381-388, 2019.

92. Battaglini CL, Hackney AC, Garcia R, Groff D, Evans E, Shea T. The effects of an exercise program in leukemia patients. Integr Cancer Ther, 8:130-138, 2009.

93. Rogers LQ, Fogleman A, Trammell R, et al. Effects of a physical activity behavior change intervention on inflammation and related health outcomes in breast cancer survivors:pilot randomized trial. Integr Cancer Ther, 12:323-335, 2013.

94. Bower JE, Greendale G, Crosswell AD, et al. Yoga reduces inflammatory signaling in fatigued breast cancer survivors:a randomized controlled trial. Psychoneuroendocrinology, 43:20-29, 2014.

95. Shimizu Y, Tsuji K, Ochi E, et al. Oncology care providers’ awareness and practice related to physical activity promotion for breast cancer survivors and barriers and facilitators to such promotion:a nationwide cross-sectional web-based survey. Support Care Cancer, 30:3105-3118, 2022.

96. Okubo R, Wada S, Shimizu Y, et al. Expectations of and recommendations for a cancer survivorship guideline in Japan:a literature review of guidelines for cancer survivorship. Jpn J Clin Oncol, 49:812-822, 2019.

97. Fukushima T, Tsuji T, Watanabe N, et al. Cancer Rehabilitation Provided by Designated Cancer Hospitals in Japan:The Current State of Outpatient Setting and Coordination after Discharge. Prog Rehabil Med, 7:20220006, 2022.